Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis.

BACKGROUND AND OBJECTIVES Patients with cystic fibrosis (CF) have a varying spectrum of clinically significant Aspergillus disease in addition to allergic bronchopulmonary aspergillosis (ABPA). Here we aimed to review the different clinical phenotypes related with Aspergillus growth on the airway culture of patients with CF, we also aimed to investigate the effect of Aspergillus growth on lung function tests. METHOD The medical records of 100 patients with CF who had Aspergillus growth on airway culture within the period of April 2001 and June 2016 were retrospectively analyzed. Age, gender, symptoms, physical examination findings, pulmonary function tests, the diagnosis of ABPA, and airway culture results were recorded for every visit. Patients with Aspergillus growth on airway cultures were classified into different groups as ABPA, Aspergillus sensitization, Aspergillus colonization and Aspergillus bronchitis. RESULTS Medical records of 83 patients and 147 sputum cultures were attained from 100 patients. The mean age of the patients was 17.6±7.6 years and the mean age of the first Aspergillus growth in sputum culture was 12.5±6.7 years. At first isolation, Aspergillus fumigatus SC was the most common Aspergillus SC in sputum (76.3%) and 14.5% of these patients required hospitalization. Aspergillus sensitization was diagnosed in 3.6% (n= 3) of the patients. Aspergillus colonization was diagnosed in 18.1% (n= 15) of all patients and led to a decline in FEV1%, FVC% and FEF25-75% which was not statistically significant, furthermore. ABPA was detected in 9.6% (n= 8) of all patients and led to a statistically significant decline in FEV1% (p= 0.02); nonsignificant decline in FVC% and FEF25-75%. Aspergillus bronchitis was detected in 43.4% (n= 36) of all patients and led to nonsignificant decline in FEV1%, FVC% and FEF25-75%. CONCLUSION ABPA is recognized as the most common Aspergillus associated disorder in CF patients and is related to deteriorated pulmonary function tests; however Aspergillus colonization and bronchitis may also be associated with worsening lung function.

[1]  C. Brandt,et al.  Aspergillus Bronchitis in Patients with Cystic Fibrosis , 2018, Mycopathologia.

[2]  A. Ralhan,et al.  Fungal Pathogens in CF Airways: Leave or Treat? , 2017, Mycopathologia.

[3]  C. Benden,et al.  Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis , 2017, Mycopathologia.

[4]  S. Chotirmall,et al.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways , 2017, Mycopathologia.

[5]  D. Denning,et al.  Aspergillosis and the role of mucins in cystic fibrosis , 2016, Pediatric pulmonology.

[6]  S. Suerbaum,et al.  Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. , 2016, Medical mycology.

[7]  A. Warris,et al.  Aspergillus infections in cystic fibrosis. , 2016, The Journal of infection.

[8]  E. Gaillard,et al.  Chronic Aspergillus fumigatus colonization of the pediatric cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. , 2016, Medical mycology.

[9]  K. Ackermann,et al.  Medically Important Fungi A Guide To Identification , 2016 .

[10]  R. Agarwal,et al.  Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta‐analysis , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  S. Doudounakis,et al.  Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[12]  D. Denning,et al.  What is the importance of classifying Aspergillus disease in cystic fibrosis patients? , 2014, Expert review of respiratory medicine.

[13]  D. Denning,et al.  Novel immunologic classification of aspergillosis in adult cystic fibrosis. , 2013, The Journal of allergy and clinical immunology.

[14]  D. Denning,et al.  IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. , 2013, Chest.

[15]  F. Askin,et al.  Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. , 2012, American journal of respiratory and critical care medicine.

[16]  J. Beekman,et al.  Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis , 2012, Current opinion in pulmonary medicine.

[17]  J. Fillaux,et al.  Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients , 2012, Scandinavian journal of infectious diseases.

[18]  S. Aaron,et al.  Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study , 2012, PloS one.

[19]  M. Bonten,et al.  Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  S. Aaron,et al.  The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. , 2010, Chest.

[21]  S. Gallati,et al.  Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. , 2006, American journal of respiratory and critical care medicine.

[22]  E. Kerem,et al.  Aspergillus bronchitis in cystic fibrosis. , 2006, Chest.

[23]  Michael Light,et al.  Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  B. Strandvik,et al.  Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. , 2001, The European respiratory journal.

[25]  J. Bargon,et al.  Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. , 1999, Respiratory medicine.

[26]  B. Ramsey,et al.  Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. , 1999, The Journal of infectious diseases.

[27]  Yvonne M Clayton,et al.  Book Review: Medically Important Fungi: A Guide to Identification , 1977 .